Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 7/20 | 0.38 |
| ▸ | MAPT | P10636 | 4/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | PDE4A | P27815 | 1/20 | 0.31 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.31 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.31 |
| ▸ | DHODH | Q02127 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13965878 | 0.91 | ABCG2 (0.31) | TOP1 | |
| SCHEMBL13965950 | 0.87 | — | — | |
| SCHEMBL1079319 | 0.86 | MAPT (0.34) | MAPTMAPK1NPSR1L3MBTL1HTT | |
| SCHEMBL19104482 | 0.84 | MAPT (0.33) | MAPTMAPK1NPSR1L3MBTL1HTT | |
| SCHEMBL16978534 | 0.84 | MAPT (0.33) | MAPTMAPK1NPSR1L3MBTL1HTT | |
| SCHEMBL15625655 | 0.84 | MAPT (0.33) | MAPTMAPK1NPSR1L3MBTL1HTT | |
| SCHEMBL13965872 | 0.84 | TOP1 (0.33) | TOP1 | |
| SCHEMBL13965868 | 0.84 | PGR (0.34) | MAPK1L3MBTL1KDM4EHPGDTSHR | |
| SCHEMBL15625656 | 0.83 | KDM4E (0.35) | MAPTMAPK1NPSR1L3MBTL1HTT | |
| SCHEMBL13965873 | 0.83 | PDK2 (0.36) | TOP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120292603-A1 | Heterocyclic compound, organic light-emitting device including the heterocyclic compound, and flat display device including the organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2012-11-22 | — | — | US | disclosed |
| US-20120292603-A1 | Heterocyclic compound, organic light-emitting device including the heterocyclic compound, and flat display device including the organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2012-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120292603-A1 | Heterocyclic compound, organic light-emitting device including the heterocyclic compound, and flat display device including the organic light-emitting device | DDT, SUN2, CYP1B1 | TOP1 2547/4885MAPT 1285/4885MAPK1 1411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.